Navigation Links
Boston Eye Group Recommends Good Hygiene with Your Contact Lenses Could Limit Your Risk of Coronavirus
Date:3/13/2020

According to the American Academy of Ophthalmology, reports suggest that the new outbreak of coronavirus can cause conjunctivitis and possibly be transmitted by aerosol or direct contact with the conjunctiva, the superficial skin layer covering the eye.

Contact lens wearers should take special precautions to avoid contracting the coronavirus. Touching the eyes while inserting contact lenses may provide a conduit for the virus to enter the body.

“Contact lens wear typically requires diligent hygiene to avoid serious eye infections but additional attention and measures should be taken in the current setting,” said Dr. Samir Melki, Chief Medical officer of the Boston Eye Group. “It is extremely important to limit your chances of infection by being extra careful with your contact lens protocol.”

To cut down on risk of transmission, individuals should avoid touching their eyes, nose or mouth with unwashed hands. Now that we know the Coronavirus may be transferred through the conjunctiva. It is very important for the population to be concerned with eye health, in particular, as it relates to contact lenses.

Dr. Li Wenliang, a Chinese ophthalmologist working in Wuhan, where the epidemic originated, was among the first to warn authorities about the outbreak last December. Subsequently, the eye doctor was infected by the coronavirus himself while treating a glaucoma patient and later died of the virus on Feb 7th.

“Cleaning and using contact lenses correctly is paramount to ensure that eyes are kept healthy and remain free from infections,” said Dr Melki. “Thorough hand washing prior to handling lenses and inserting them into one’s eyes is very important to reduce the risk of infection.”

If you have symptoms of conjunctivitis and have recently traveled to an at risk region for the coronavirus, Dr. Melki recommended discontinuing contact lens use and discussing your symptoms with a provider before coming to the office or hospital.

Boston Eye Group/Boston Laser is a multifaceted ophthalmology practice, with locations in Brookline, Wellesley, Medford, Wellesley, Andover, Lawrence, Norwood, West Roxbury, Norfolk and Milford, MA. Boston Eye Group offering a wide range of eye services. http://www.Bostonlaser.com. 617-277-4733. For media inquiry, please email Rick@bostonlaser.com.

Read the full story at https://www.prweb.com/releases/boston_eye_group_recommends_good_hygiene_with_your_contact_lenses_could_limit_your_risk_of_coronavirus/prweb16969842.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology news :

1. China Focus@Biotech Week Boston to be Held in September
2. KMK Consulting, Inc. Expands Presence in Boston to Help Biotechnology Companies from Pre-Launch to Commercialization
3. Leading Boston-Based Conference Company and Publisher Expands Portfolio Internet of Things (IoT)
4. Greenberg Traurig Hosts Boston Healthcare Drinks and Discussion on China Biopharma Industry
5. Avastus Opens New Vivarium to Serve the Preclinical Research Needs of Boston’s Biotech Community
6. Heart Health Innovator Boston Heart Diagnostics Joins American College of Lifestyle Medicine Corporate Roundtable
7. George Golumbeski, President of GRAIL, Inc. to Deliver Keynote at BD Boston 2018
8. Boston Colleges Amir Hoveyda receives Italys Eni Award for Hydrocarbons Research
9. Boston Police Chief to Address Boston Marathon Bombings at IEEE Homeland Security Conference in Waltham, Mass., on 12 November
10. Enterprises Boost Investment in Application Transformation Initiatives by 64% in 2019—Everest Group
11. New MyOnyx Rehab Solution Allows Better Targeting and Training of Specific Muscle Groups
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/5/2020)... ... August 05, 2020 , ... Regenative Labs has received approval ... CoreText™ and ProText™, making them the first Wharton’s jelly allografts to be assigned a ... The company’s solutions are the first Wharton’s jelly allograft product to be recognized as ...
(Date:7/31/2020)... ... July 30, 2020 , ... Justin Zamirowski ... with a near term focus on Type 2 diabetes and associated comorbidities. , ... multiple therapeutic areas and classes. As Chief Commercial Officer, Justin will lead ...
(Date:7/18/2020)... ... 17, 2020 , ... Commercial launch readiness is a critical stage in a ... cure or vaccine, the global economic downturn will only increase price pressures overall for ... and capturing full value from every product launch is critical. However, history shows that ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... ... R3 Stem Cell International is now offering patients the opportunity to receive four ... may choose which extremities they would like treated. , Several studies have shown just ... R3 International, umbilical cord tissue is obtained from a lab with a long history ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, ... have entered into a strategic partnership whereby Catalent will provide support for the ...
(Date:7/22/2020)... (PRWEB) , ... July 22, 2020 , ... Join experts ... John Lorenc, Sr. Manager Regulatory Solutions, in a one hour live webinar ... the regulating body in China for drugs and medical devices. Specifically, for medical devices, ...
(Date:7/18/2020)... ... July 17, 2020 , ... dicentra , ... sciences and food industries, is pleased to announce that Charles Galea has joined ... Development. , Charles is an accomplished and results-driven sales executive with over 10 ...
Breaking Biology Technology: